-+ 0.00%
-+ 0.00%
-+ 0.00%

TARSUS PHARMACEUTICALS - TO BEGIN PHASE 3 IRX-101 STUDY IN H1 2027, RESULTS EXPECTED 2028

Reuters·07/08/2026 20:05:01

Please log in to view news